Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 2 (2)

Trial Status

Recruiting1
Not Yet Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07485010Phase 2Not Yet RecruitingPrimary

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

NCT07295938Phase 2RecruitingPrimary

TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

Showing all 2 trials

Research Network

Activity Timeline